Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01044693 · ClinicalTrials.gov registry record · NA
Nebivolol in the Supine Hypertension of Autonomic Failure
A NA study, sponsored by Vanderbilt University.
- Completed
- Registry status
- NA
- Development phase
- 20
- Enrollment target
NCT01044693 is a NA study that has completed, run by Vanderbilt University. The registered enrollment target is 20 participants.
The verdict
NCT01044693, a NA study, has completed, sponsored by Vanderbilt University.
- COMPLETED
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the effect of the antihypertensive drug, nebivolol (Bystolic), compared to metoprolol (Lopressor) and sildenafil (Viagra) on blood pressure in patients with autonomic failure and supine hypertension.
Interventions
- DRUG Placebo
- DRUG Nebivolol 5 mg
- DRUG metoprolol tartrate 50 mg
- DRUG Sildenafil25 mg
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2010-01 |
| Est. Completion | 2014-08 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01044693
The ClinicalTrials.gov registry entry for NCT01044693 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Vanderbilt University, which has 430 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Placebo is the first listed.
NCT01044693 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01044693 about?
NCT01044693 is a clinical study titled "Nebivolol in the Supine Hypertension of Autonomic Failure". The purpose of this study is to evaluate the effect of the antihypertensive drug, nebivolol (Bystolic), compared to metoprolol (Lopressor) and sildenafil (Viagra) on blood pressure in patients with autonomic failure and supine hypertension.
What is the current status of trial NCT01044693?
This trial is currently completed. It is a NA study. The enrollment target is 20 participants. The study started on 2010-01. Estimated completion is 2014-08.
What interventions are being tested in trial NCT01044693?
The interventions under investigation include: Placebo (DRUG), Nebivolol 5 mg (DRUG), metoprolol tartrate 50 mg (DRUG), Sildenafil25 mg (DRUG).
Who is sponsoring clinical trial NCT01044693?
This trial is sponsored by Vanderbilt University, which has 430 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.